Upon
completion of this CME activity, participants should be able to:
Describe the current American Cancer Society/US Multi-society Task Force on Colorectal Cancer/American College of Radiology recommendations for colorectal cancer screening.
Identify common risk factors for development of colorectal cancer.
Determine the role of inherited disease in the development of colorectal cancer.
The faculty has no commercial affiliations to disclose.
Because of the nature of preliminary studies, some products
mentioned are unlabeled and investigational. Dosages,
indications, and methods of use of drugs mentioned in
this publication may reflect the experience of the authors,
clinical literature, or other resources. Therefore, please
see the full prescribing information before using any
licensed product mentioned.
CME PARTICIPATION:
To
participate in this online course
for CME credit, please review the
objectives before beginning the program.
Complete the course and the self-assessment
test before February 29, 2011 to receive
CME credit. Your certificate will
then be available online. This process
should take approximately 1 hour.
The
University of Alabama School of
Medicine is accredited by the Accreditation
Council for Continuing Medical
Education to provide continuing
medical education for physicians.
The
University of Alabama School of
Medicine designates this educational
activity for a maximum of 1 AMA
PRA Category 1 Credit™.
Physicians should only claim credit
commensurate with the extent of
their participation in the activity.
The
boards of nursing in many states,
including Alabama, recognize Category
1 continuing medical education
courses as acceptable activities
for the renewal of license to practice
nursing.
Dosages, indications, and methods of use of any drug referred
to in this publication may reflect the clinical experience
of the authors, clinical literature, or other clinical
resources. Therefore, please see the full prescribing
information before using any product mentioned. UAB
is an equal opportunity/affirmative action institution.
An estimated 148,810 cases of colon and rectal cancer are expected to occur in the United States during 2008. Approximately 49,960 Americans are expected to die this year from this disease. Colorectal cancer (CRC) is the nation’s second leading cause of cancer mortality. It is also one of the most preventable cancers. Increased adherence to colorectal cancer screening guidelines would result in increased detection and removal of pre-cancerous polyps, detection of cancers at earlier stages, increased survival, and reduced mortality rates.
A 48-year-old female comes in the clinic for an initial visit. She has no complaints, but is concerned about her risk for colorectal cancer. She has no family history of colorectal cancer, no other colorectal cancer risk factors, no signs or symptoms (such as rectal bleeding) to suggest colorectal cancer, and has not been screened for colorectal cancer. Her physical exam is normal.
